Dublin, Feb. 13, 2020 (GLOBE NEWSWIRE) -- The "Androgenetic Alopecia - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Androgenetic Alopecia Pipeline ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. ET-02 is a topical treatment that targets hair follicle ...

If you’re reading this because you’re losing your hair, you’re not alone — hair loss is a common issue affecting more than half of men by the time they’re in their forties. The most common type of ...

BOSTON--(BUSINESS WIRE)--Follica, Inc. [“Follica”], a biotechnology company developing a regenerative platform designed to treat androgenetic alopecia (AGA), epithelial aging and other related ...

Androgenetic alopecia is a common form of hair loss in both women and men. Those with androgenetic alopecia may experience regrowth of hair, but the rate of regrowth is different for everyone.

SUWON, South Korea--(BUSINESS WIRE)--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced today that it has received approval from the Human Research Ethics ...

A study evaluates the risk for osteoporosis or osteopenia associated with 5-alpha reductase inhibitors in women with two ...

According to a 48-week study, home-based, helmet-type low-level laser therapy (LLLT) used three times weekly significantly ...

Researchers at the San Carlos Clinical Hospital in Madrid may have targeted a potential solution for hair loss. A recent study analyzed the effect of injecting mice's skin with stem cells from human ...

If you’re reading this because you’re losing your hair, you’re not alone — hair loss is a common issue affecting more than half of men by the time they’re in their forties. The most common type of ...